Entera Bio Ltd.(ENTX)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Entera Bio Ltd. (ENTX) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ENTX at 17.0/100 on a 32-signal composite quality model, placing it at rank #2,831 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), Entera Bio Ltd. reports net income of $-7.3M, free cash flow of $-3.5M. Top institutional holders of ENTX by reported 13-F value include Knoll Capital Management, BVF, Siren, L.L.C., based on the most recent SEC filings. ENTX trades on the Nasdaq exchange and files with the SEC under CIK 1638097. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ENTX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Entera Bio Ltd. directly from SEC EDGAR.